Navigation Links
NextDocs and Novella to Present on eTMF at DIA 2013
Date:6/19/2013

CONSHOHOCKEN, Pa., June 19, 2013 /PRNewswire/ -- NextDocs announced today that it will co-present with Novella, a full service clinical research organization, at DIA 2013, the Drug Information Association annual meeting and conference.  The companies will present case studies that explore best practices for making the transition from paper trial master file to electronic trial master file (eTMF) systems.

Sharon Ames, enterprise program director at NextDocs will present alongside Krystyna Kowalczyk, executive vice president of clinical operations at Novella, in a session entitled, "That Awkward Stage: Transitioning from Paper Trial Master File to eTMF."  The session will examine how to structure a paper-to-electronic transition that incorporates the needs of ongoing studies while also meeting regulatory needs and reducing operational impacts. 

DIA 2013, the 49th annual meeting and conference of the DIA, is the largest multidisciplinary event for the pharmaceutical and life sciences industry, focusing on advancing therapeutic innovation and regulatory science.  The DIA 2013 conference takes place at the Convention and Exhibition Center in Boston from June 23 - 27, 2013. 

NextDocs and Novella's session, "That Awkward Stage: Transitioning from Paper Trial Master File to eTMF," will take place on Monday, June 24, 2013 at 2:30 p.m.  Additionally, NextDocs will be demonstrating its solutions at the DIA conference in booth #1722.

For more information on DIA 2013, visit www.diahome.org.   For more information on NextDocs, visit www.nextdocs.com.

CONTACT:
Dan Cahill
1-917-617-0106
dcahill@roaringpr.com


'/>"/>
SOURCE NextDocs
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NextDocs Expands Customer Roster by More Than 10 Percent
2. NextDocs Launches QuickStart for Emerging Growth Companies
3. NextDocs 6: The New Enterprise Standard for Regulated Content Management
4. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
5. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
6. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
7. Pharma IQ Presents the Latest Trends in Clinical Trial Supply
8. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
9. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
10. Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
11. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):